Investment research summary
Four-master Research Compression
Business essence: what customers pay for
Under Armour sells performance apparel, footwear, and accessories that athletes and active consumers use for training, running, team sports, and daily wear. The value proposition is technically engineered gear that manages moisture, temperature, and comfort during physical activity. Apparel generates roughly 68% of revenue (about $3.4 billion in FY2026), footwear about 22% ($1.08 billion), and accessories, licensing, and other the remainder. North America is still the largest region despite a steep multi-year decline, with EMEA up 9% in FY2026 and APAC down 5%. The brand retains strength with competitive and college athletes but has lost broader cultural relevance to Nike, Lululemon, Hoka, and ON.
Moat: brand, switching costs, scale
Under Armour has real but narrow moats. The brand has credibility in specific niches such as baseball, football, running (back-to-back Boston Marathon wins for Sharon Lokedi), college athletics, and tactical gear, and its base layer and compression franchise remains a competitive advantage. However, consumer switching costs are low, pricing power in the broader market is weak, and the company lacks the scale of Nike, which is several times larger. Technology moats are thin because compression and moisture management fabrics are widely replicated. Morningstar characterizes Under Armour as lacking a durable competitive edge while noting the focus on performance athletes provides comeback hope. The moat is narrower today than it was in 2015 when the brand grew more than 20% annually.
Munger risk inversion: thesis failure paths
The Under Armour thesis fails if: (1) the North America wholesale channel keeps shrinking as retailers allocate floor space to Nike, Lululemon, Hoka, and ON instead of UA; (2) footwear remains a loss-making category where the brand cannot compete on performance or style; (3) the assumed IEEPA tariff refund is delayed or reduced, breaking the fiscal 2027 gross margin plan; (4) the Middle East conflict adds materially more than the roughly $35M guided headwind; (5) debt of $1.94 billion combined with negative operating cash flow forces a dilutive raise or distressed refinancing; or (6) the Protect This House 3 plan fails to translate into revenue stabilization, leaving the company in a low-growth, low-margin equilibrium.
Management: Kevin Plank and the turnaround team
Founder Kevin Plank, who stepped down as CEO in 2020 after accounting and governance issues, returned as CEO in April 2024 and launched Protect This House 3. The plan cut SKUs by 25%, moved to category management across roughly a dozen sports, and shifted priorities from growth-at-all-costs to profitability and balance sheet strength. New CFO Reza Taleghani joined in early 2026 with a capital discipline mandate, and a new Chief Merchandising Officer was named to further edit the assortment. Plank holds a controlling founder-level stake with supervoting power. Key-person risk is significant: the turnaround strategy would lose credibility if Plank left, and the management team has a multi-year execution record that has not yet produced GAAP profitability.
Industry trend: apparel and athleisure competitive dynamics
The global athletic apparel and footwear market is growing at a mid-single-digit rate, but growth is concentrated in women, outerwear, premium running, and performance lifestyle where Under Armour under-indexes. Nike remains dominant, Lululemon owns the premium yoga and athleisure segment, and Hoka and ON have captured the running footwear category. Under Armour leads in baseball, softball, and tactical gear but is not a leader in any large category. UBS notes US website traffic rose 23% year over year in fiscal Q1 2027 and discounting fell about 250 basis points, early signs that the premiumization and digital strategy is working. Tariffs and the Middle East conflict add uncertainty for a company already under margin pressure.
Valuation and margin of safety
At $6.78, UAA trades at 0.58x trailing sales and about 2.04x book value, well below historical averages and peer multiples, which reflects unprofitability, debt, and negative free cash flow. The forward P/E of about 60-64x on guided adjusted EPS of $0.08-$0.12 prices in a return to profitability in fiscal 2027. Consensus is Hold with an average 12-month target of $6.28, slightly below the current price. UBS values the stock at $10 using roughly 14x its fiscal 2029 adjusted EPS estimate of $0.70; Evercore and Citi sit at $4.00 and $4.75. The margin of safety is low for a company with no GAAP profitability, negative operating cash flow, and high short interest.
